Semaglutide is the active ingredient in the widely recognized weight loss medications Ozempic and Wegovy. It works by mimicking a hormone that targets areas of the brain involved in regulating appetite and food intake, leading to reduced cravings and significant weight loss.
Semaglutide works by mimicking a hormone that targets areas of the brain involved in regulating appetite and food intake, leading to reduced hunger and significant weight loss. Our semaglutide is sourced from a reputable 503A compounding pharmacy and a domestic API manufacturer. The pharmaceutical facility follows strict cGMP (current Good Manufacturing Practices) guidelines to ensure the highest safety standards. To further enhance the effectiveness of the treatment, each injection also contains vitamin B12 to reduce nausea and glycine to protect muscle health during weight loss. For patients who prefer brand-name options, we offer prescriptions for Ozempic and Wegovy when applicable.
Get Started for Just $399/Month Including $50 Towards Nutrition
Transform your health with our popular Medical Weight Management Program at Flagstaff Optimal Health & Weight Management. Achieve enhanced weight loss through semaglutide injections, combined with personalized consultations from Megan Engbring, DNP, FNP-C, who will guide you every step of the way. Our comprehensive program includes lab testing to assess your cardiovascular risk, monthly check-ins, and expert coaching on sustainable health habits for long-lasting results. You’ll receive four pre-filled semaglutide syringes, compounded with B12 to reduce nausea and Glycine to support muscle health, along with biometric monitoring and body composition analysis to track your progress. Enroll during your new patient consultation and we’ll waive your consultation fee, plus save an additional $50 when you combine the program with our Nutrition or Muscle Support Systems.
Why We Prescribe Semaglutide
Obesity is a medical condition with serious health implications. It is associated with over 60 weight-related comorbidities, including high blood pressure, dyslipidemia, and type 2 diabetes, all of which significantly increase cardiovascular risk. In fact, cardiovascular disease remains the leading cause of death in adults with obesity. Research shows that men and women with obesity are at a significantly higher risk for heart attacks. Obese women face a 75% greater risk for non-fatal myocardial infarction, while obese men have a 42% greater risk compared to those at a healthy weight. These statistics underscore the urgent need for effective medical interventions in obesity treatment, with the goal of not only weight reduction but also the prevention of cardiovascular events. With over 20 years of experience in cardiovascular medicine and preventive healthcare, Megan Engbring, DNP, FNP-C, is a recognized leader in the field of cardiovascular care, specializing in integrating weight management and holistic lifestyle approaches to optimize cardiovascular health.
NHLBI. 2013. Managing Overweight and Obesity in Adults: Systematic Evidence Review from the Obesity Expert Panel.
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults.
How GLP-1 Inhibitors Work
GLP-1 receptor agonists work by mimicking the action of glucagon-like peptide-1 (GLP-1), a hormone naturally produced in the body that plays a key role in regulating appetite and glucose metabolism. These medications bind to GLP-1 receptors in the brain, reducing hunger and increasing feelings of fullness, which leads to decreased food intake and weight loss. Additionally, GLP-1 receptor agonists slow gastric emptying and enhance insulin secretion while suppressing glucagon release, which helps regulate blood sugar levels and contributes to improved metabolic control.
Proven Benefits of Semaglutide for Cardiovsacular Risk Reduction
In addition to promoting weight loss, semaglutide has been shown to provide a 20% relative risk reduction in major adverse cardiovascular events, such as heart attack and stroke, when added to standard cardiovascular care. Patients on Wegovy have also experienced improvements in other key health metrics, including lipid profiles, blood pressure, weight, and waist circumference. This makes semaglutide a powerful tool not only for weight management but also for reducing the risks of cardiovascular disease, the number one cause of death in adults with obesity.
Our Focus: Medical Weight Management to Improve Health Outcomes
At Flagstaff Optimal Health & Weight Management, we differentiate ourselves by treating obesity with a clear focus on long-term health benefits, particularly cardiovascular risk reduction. Unlike many other providers, we prioritize the medical necessity of weight loss for our patients’ overall health and longevity. Our personalized weight loss plans, including semaglutide injections, are designed to help patients reduce their cardiovascular risk, improve metabolic health, and achieve sustainable results. We understand the complexity of obesity and are here to provide expert guidance and support every step of the way. Our comprehensive, science-driven approach sets us apart, offering a solution that addresses not only weight loss but also the underlying health risks associated with obesity.
Frequently Asked Questions
Don’t see your question answered here? Book a consultation with us to discuss your medication eligibility.